Skip to main content
Funded Studies

Jeffrey P. MacKeigen, PhD

Professor at Michigan State University

Location: Grand Rapids, MI United States

Jeffrey P. MacKeigan, PhD, completed his undergraduate training in molecular, cellular and developmental biology at the University of Colorado in Boulder, Colorado. In 2002, he received his PhD in microbiology and immunology from the University of North Carolina. Dr. MacKeigan then served as a postdoctoral fellow in the Department of Cell Biology at Harvard Medical School. In 2004, he joined Novartis Institutes for Biomedical Research in Cambridge, Massachusetts, as a project leader in the Molecular and Developmental Pathways expertise platform. Dr. MacKeigan joined Van Andel Research Institute in June 2006 and Michigan State University in 2017 as professor of cancer biology and complex diseases. His research focuses on studying drug targets for neurological disorders and on designing neuroprotective strategies for the treatment of Parkinson's disease.

Associated Grants

  • Investigating the Neuroprotective Potential and Mechanism of Action of an Inhibitor of the Rho-associated Protein Kinase (ROCK)


  • A ROCK Inhibitor as a Neuroprotective Therapy for Parkinson's Disease


  • Fasudil as a Novel Therapeutic for the Treatment of Parkinson's Disease


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.